Kailera Therapeutics, Inc.
KLRACIK 0002096997 · Every Form 4 filed by insiders at this issuer. See financials →
Recent 8-K announcements
Per-item disclosure feed. Item 2.02 is the earnings release.
Top insiders
Most active reporters at Kailera Therapeutics, Inc.
| Name | Roles | Filings |
|---|---|---|
| Hite Christopher | Director | 1 |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10% Owner | 1 |
| Kaplan Andrew T. | Director10% Owner | 1 |
| Koppel Adam | Director10% Owner | 1 |
| MacKay Martin | Director | 1 |
All filings
17 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|